A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism. Human molecular genetics, ddac170
Genome-Edited Coincidence and PMP22-HiBiT Fusion Reporter Cell Lines Enable an Artifact-Suppressive Quantitative High-Throughput Screening Strategy for PMP22 Gene-Dosage Disorder Drug Discovery